Carl Zeiss Meditec AG Profile Avatar - Palmy Investing

Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and …

Medical - Instruments & Supplies
DE, Jena [HQ]

Ratios

14 Records · Starting from 2010
Margins, Growth Rates In %
Ratio 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
53.01 54.67 53.53 53.82 53.71 51.89 53.25 55.19 55.46 57.00 55.83 58.73 59.26 57.71
Profit Margin
8.81 9.52 8.34 10.32 8.24 5.99 9.03 11.30 9.87 10.95 9.16 14.35 15.45 13.90
Operating Margin
12.82 13.65 14.26 14.77 13.28 12.56 14.18 15.36 15.39 16.31 15.47 21.16 21.71 20.48
EPS Growth
9.68 20.59 7.32 28.41 -18.58 -16.30 57.14 29.75 -10.19 26.95 -23.46 92.70 24.62 -1.22
Return on Assets (ROA)
7.09 8.33 7.46 9.54 7.21 5.47 7.88 8.28 7.61 7.90 6.08 9.86 10.41 9.57
Return on Equity (ROE)
10.42 12.07 10.97 13.39 10.48 8.26 12.32 11.06 9.78 11.42 8.55 14.24 14.59 13.45
Return on Invested Capital (ROIC)
10.56 12.17 11.78 12.62 11.45 10.99 13.47 10.77 10.65 11.42 9.51 13.71 14.14 13.08
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
2.16 1.23 3.21 1.46 1.28 1.07 0.72 0.36 0.65 2.84 3.41 5.06 4.53 5.13
Debt/Equity
3.18 1.79 4.72 2.05 1.85 1.62 1.13 0.48 0.84 4.11 4.79 7.31 6.35 7.21
Debt/EBITDA
-268.89 -144.84 15.26 4.64 1.86 -0.61 0.16 0.91 1.98 12.17 23.74 27.76 24.89 28.91
Debt/Capitalization
3.08 1.75 4.51 2.01 1.82 1.60 1.11 0.48 0.83 3.95 4.57 6.81 5.97 6.73
Interest Debt per Share EUR
0.30 0.22 0.45 0.26 0.20 0.18 0.15 0.10 0.15 0.73 1.08 1.46 1.54 1.91
Debt Growth
-0.20 -41.20 188.92 -53.70 -7.41 -7.75 -26.54 -35.26 86.62 429.85 19.34 76.77 5.47 21.73
Liquidity
Current Ratio
348.45 371.67 331.62 354.88 347.78 318.95 300.40 382.15 446.52 384.08 434.42 357.95 332.25 340.38
Quick Ratio
280.06 294.19 264.71 283.24 261.62 241.13 227.54 308.02 357.97 305.07 338.19 294.04 261.28 247.75
Cash Ratio
179.86 112.89 4.46 3.03 5.36 5.36 3.05 1.24 2.38 6.67 1.75 1.66 1.43 1.89
Operating Cash Flow Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
266.71 257.45 280.05 281.96 244.13 264.18 244.26 227.55 229.94 233.84 206.01 237.30 202.55 169.84
Receivables Turnover
413.47 396.13 - - 156.11 - - - - - - - - - - 145.88 136.28 127.20 139.26 161.07
Payables Turnover
803.24 811.22 1,084.37 751.65 842.64 754.57 588.02 530.71 562.39 531.19 643.48 467.17 409.78 368.46
Asset Turnover
80.44 87.47 89.51 92.44 87.50 91.29 87.23 73.31 77.06 72.17 66.33 68.73 67.41 68.89
Coverage
Interest Coverage
1,474.47 1,444.23 2,020.38 2,031.16 4,098.64 4,700.90 4,292.96 6,777.56 7,419.27 2,899.73 740.84 3,720.40 4,306.08 2,805.34
Asset Coverage
3,400 6,200 2,400 5,300 6,000 6,900 10,100 21,300 12,000 2,700 2,300 1,400 1,600 1,400
Cash Flow Coverage (CFGR)
358.42 350.95 297.97 451.57 476.23 464.20 1,244.65 648.99 1,725.41 382.05 260.22 299.05 147.14 161.12
EBITDA Coverage
1,800 1,700 2,300 2,600 4,500 4,800 4,600 7,600 7,900 3,400 900 4,300 5,000 3,200
Dividend Coverage
-400 -100 -200 -200 -200 -100 -300 -300 -200 -300 -200 -500 -300 -200
Time Interest Earned (TIE)
100 100 100 100 100 100 100 100 100 100 100 100 100 100
Market Prospects
Dividend Yield
1.56 4.12 1.50 1.81 1.96 1.60 1.12 0.99 0.75 0.53 0.60 0.30 0.84 1.33
Earnings Yield
6.35 6.65 4.42 5.21 4.01 3.07 3.55 3.56 1.94 1.71 1.27 1.59 3.06 3.92
Price/Earnings (P/E)
15.7476 15.0303 22.6269 19.1915 24.9502 32.6298 28.1396 28.1183 51.5937 58.5611 78.9278 62.8570 32.6985 25.5082
Price/Book (P/B)
164.10 181.34 248.28 256.94 261.46 269.64 346.81 311.04 504.44 668.99 674.69 895.04 476.92 343.03
Price/Sales (P/S)
138.78 143.16 188.68 197.97 205.68 195.44 254.23 317.71 509.40 641.08 723.32 901.85 505.06 354.54
Price/Cash Flow (P/CF)
1,440.13 2,893.32 1,765.68 2,776.84 2,963.51 3,582.30 2,475.59 10,018.99 3,485.28 4,259.58 5,410.71 4,095.15 5,106.50 2,952.82